Literature DB >> 12376235

Intestinal obstruction due to tuberculosis.

Van Hai Nguyen1.   

Abstract

OBJECTIVES: Intestinal obstruction due to tuberculosis is a rare form of mechanical bowel obstruction. The objectives of this study were to determine the clinical features, to evaluate the role of surgery and to choose procedures in management of this disease.
METHODS: In this 7-year retrospective study (from 1992 to 1998), 23 patients (20 males, three females) were included, accounting for 4.5% of all mechanical intestinal obstructions. More than 80% of the patients had a clinical picture of lower small bowel obstruction, while 90.5% of patients had advanced pulmonary tuberculosis.
RESULTS: In 54.6% of cases, obstruction occurred in the ileocaecal region. The main lesion causing obstruction was intestinal tuberculosis in the hypertrophic form (86.4%). Diagnosis of intestinal tuberculosis as a cause of obstruction was not easy because it has no specific symptoms and signs.
CONCLUSION: In terms of management, ileocolostomy was often used (68.2%) but long-term results were not very good. Blind loop syndrome was one of its disadvantages. Resection may be the safe and effective procedure.

Entities:  

Mesh:

Year:  2002        PMID: 12376235     DOI: 10.1016/S1015-9584(09)60163-9

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  2 in total

1.  Rehabilitation towards functional independence in patient with abdominal tuberculosis undergone abdominal surgery: a case report.

Authors:  Shivani Satish Lalwani; Moli Jai Jain; Vishnu Diwakar Vardhan; Vaishnavi Dilip Yadav; Tasneem Mustafa Lakkadsha; Sakina Shoeb Hussain Saifee
Journal:  Pan Afr Med J       Date:  2022-03-10

2.  Tuberculous bowel obstruction at a university teaching hospital in Northwestern Tanzania: a surgical experience with 118 cases.

Authors:  Mabula D Mchembe; Stephen E Mshana; Peter Rambau; Hyasinta Jaka; Joseph B Mabula; Phillipo L Chalya
Journal:  World J Emerg Surg       Date:  2013-03-16       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.